Upper Gastrointestinal Tract Lymphoma With Natalizumab: Evidence of Impaired Immune Surveillance?

Neurol Clin Pract. 2021 Aug;11(4):e546-e548. doi: 10.1212/CPJ.0000000000000985.

Authors

Lauren Gomes¹, Emily Watson¹, Matthew Robert Smith¹, Edward Morris¹, Mike Boggild¹

Affiliation

¹ Department of Neurology (LG, MB), Townsville University Hospital; Department of Neurology (EW), PA Hospital, Brisbane; Department of Gastroenterology (MRS), and Department of Haematology (EM), Townsville University Hospital, Queensland, Australia.

No abstract available

Publication types

Case Reports